CXCR3 and neoplasm: In patients with ovarian cancer, IL-17 derived from Th17 cells has been shown to induce the production of CXCL9 and CXCL10 by tumor cells and tumor infiltrated macrophages, which recruits CXCR3-expressing CTLs and NK cells into tumor tissues [139].